StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet
Marketer
Sarvagunaushdhi Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet
Diabetics using the combined medication Glimepiride/Metformin/Voglibose (1mg/500mg/0.3mg) should be aware that it's an anti-diabetic formulation for managing type 2 diabetes in adults. This triple-action tablet helps regulate blood glucose. Always ingest it with food, maintaining a consistent daily schedule for optimal efficacy. Dosage is personalized and subject to adjustment based on your blood sugar readings, as determined by your physician. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember that this medication is one component of a comprehensive diabetes management plan, including diet modification, physical activity, and weight control as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to recognize its symptoms—sweating, dizziness, headache, tremors—and how to treat it promptly. Maintain regular meals and carry readily available glucose sources (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Individuals with a history of heart disease should inform their doctor before starting this treatment. Pregnant or nursing mothers require medical consultation before use. Regular blood sugar monitoring is essential, along with periodic blood tests to assess blood cell counts and liver function.
Primary Ingredients of StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet should be consumed on an empty stomach.
Common Side effects of StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet on an empty stomach.
How StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet works:
Tri-action diabetes medication StayHappi combines glimepiride (1mg), metformin (500mg), and voglibose (0.3mg) in a single tablet.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The use of StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg tablets is likely inadvisable for individuals with kidney impairment and should be eschewed. A physician's consultation is advised. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Individuals with liver impairment should use StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablets cautiously, potentially requiring dosage modification. Medical advice is essential. Low initial doses are typically prescribed for patients with mild to moderate liver disease; however, the medication is unsuitable for those with severe liver dysfunction.
What if you forget to take StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet :
Should you forget a dose of StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About StayHappi Glimepiride+Metformin+Voglibose 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently